| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 3 |
| 1 | CARBOPLATIN | 2 |
| 2 | CARFILZOMIB | 2 |
| 3 | CYCLOPHOSPHAMIDE | 2 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 6 | DEXAMETHASONE | 2 |
| 7 | DEXAMETHASONE 1.5 MG | 2 |
| 8 | DOCETAXEL | 2 |
| 9 | DOCETAXEL ANHYDROUS | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 1 | VINORELBINE | 2 | 0.0003 |
| 2 | CARMUSTINE | 1 | 0.0002 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | TRETINOIN | 1 | 0.0001 |
| 5 | CARFILZOMIB | 2 | 0.0001 |
| 6 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 7 | NINTEDANIB | 2 | 0.0001 |
| 8 | MERCAPTOPURINE | 1 | 0.0001 |
| 9 | PEMETREXED DISODIUM | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 3 | Proteasome Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Retinoid [EPC] | 1 | 0.0000 |